Skip to content

Effectiveness of Bogers Philosophy in Homoeopathic Management of Allergic Rhinitis Among Adults

Effectiveness of Boger's Philosophy in Homoeopathic Management of Allergic Rhinitis Among Adults : An Experimental Non - Controlled Study - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095927
Enrollment
40
Registered
2025-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Bogers Philosophy: Boger’s Philosophy of forming totality which gives prior importance to pathological generals, ailments from, modalities and time modalities will be considered in for

Sponsors

Dr Riddhi Ladniya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Perennial Allergic Rhinitis. Patients of age group 20 to 40. Patients of all genders. Patients with controlled systemic comorbidities

Exclusion criteria

Exclusion criteria: Patients of Seasonal Allergic Rhinitis and Rhinoconjunctivitis. Patients of Perennial Allergic Rhinitis with associated Nasal and Respiratory disorders such as bronchial asthma, sinusitis respectively. Patients of Perennial Allergic Rhinitis with local comorbidities such as urticaria. Immuno-compromised patients. Pregnant or lactating women. Patients on any medication like Antihistamines/ Antibiotics, within 3 months prior to the study.

Design outcomes

Primary

MeasureTime frame
Outcome will be assessed in terms of- 1. Improved 2. Not improvedTimepoint: Outcome will be assessed at 0 days (baseline), 1 month, 3 months, 6 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Chintan Mehta

DR. G. D. Pol Foundation YMT Homoeopathic Medical College and PG Institute

snehom5@gmail.com9322506976

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026